{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:54:41Z","timestamp":1789944881927,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41386-018-0039-3","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T15:52:43Z","timestamp":1519746763000},"page":"1772-1778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures"],"prefix":"10.1038","volume":"43","author":[{"given":"Laura C.","family":"Politte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"39_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edn. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5th edn"},{"key":"39_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5:160\u201379.","journal-title":"Autism Res"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"E Fombonne","year":"2009","unstructured":"Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591\u20138.","journal-title":"Pediatr Res"},{"key":"39_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1517\/14656566.2016.1154536","volume":"17","author":"RE Accordino","year":"2016","unstructured":"Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ. Psychopharmacological interventions in autism spectrum disorder. Expert Opin Pharmacother. 2016;17:937\u201352.","journal-title":"Expert Opin Pharmacother"},{"key":"39_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaac.2015.08.013","volume":"54","author":"BL Handen","year":"2015","unstructured":"Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, et al. Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:905\u201315.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","volume":"51","author":"M Harfterkamp","year":"2012","unstructured":"Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012;51:733\u201341.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","volume":"62","author":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network.","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266\u201374.","journal-title":"Arch Gen Psychiatry"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/cap.2012.0096","volume":"23","author":"DA Pearson","year":"2013","unstructured":"Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, et al. Effects of extended release methylphenidate treatment on ratings of attention-deficit\/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. J Child Adolesc Psychopharmacol. 2013;23:337\u201351.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR9","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s10803-013-1793-z","volume":"43","author":"B Reichow","year":"2013","unstructured":"Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit\/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord. 2013;43:2435\u201341.","journal-title":"J Autism Dev Disord"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","volume":"172","author":"L Scahill","year":"2015","unstructured":"Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, et al. Extended-release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry. 2015;172:1197\u2013206.","journal-title":"Am J Psychiatry"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/cap.2006.16.611","volume":"16","author":"PW Troost","year":"2006","unstructured":"Troost PW, Steenhuis MP, Tuynman-Qua HG, Kalverdijk LJ, Buitelaar JK, Minderaa RB, et al. Atomoxetine for attention-deficit\/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study. J Child Adolesc Psychopharmacol. 2006;16:611\u20139.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/NDT.S65735","volume":"11","author":"J Martinez-Raga","year":"2015","unstructured":"Martinez-Raga J, Knecht C, de Alvaro R. Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder. Neuropsychiatr Dis Treat. 2015;11:1359\u201370.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"39_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","volume":"129","author":"M Wang","year":"2007","unstructured":"Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007;129:397\u2013410.","journal-title":"Cell"},{"key":"39_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/cap.2013.0103","volume":"24","author":"RL Findling","year":"2014","unstructured":"Findling RL, McBurnett K, White C, Youcha S. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014;24:245\u201352.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/cap.2016.0132","volume":"27","author":"JR Strawn","year":"2017","unstructured":"Strawn JR, Compton SN, Robertson B, Albano AM, Hamdani M, Rynn MA. Extended release guanfacine in pediatric anxiety disorders:a pilot, randomized, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2017;27:29\u201337.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/cap.2012.0119","volume":"23","author":"DF Connor","year":"2013","unstructured":"Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244\u201351.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/cap.2017.0024","volume":"27","author":"TK Murphy","year":"2017","unstructured":"Murphy TK, Fernandez TV, Coffey BJ, Rahman O, Gavaletz A, Hanks CE, Tillberg CS, Gomez LI, Sukhodolsky DG, Katsovich L, Scahill L. Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J Child Adolesc Psychopharmacol. 2017;27:762\u201370. \n                    https:\/\/doi.org\/10.1089\/cap.2017.0024\n                    \n                  .","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.sleep.2013.10.018","volume":"15","author":"D Efron","year":"2014","unstructured":"Efron D, Lycett K, Sciberras E. Use of sleep medication in children with ADHD. Sleep Med. 2014;15:472\u20135.","journal-title":"Sleep Med"},{"key":"39_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1087054714554932","volume":"22","author":"TA Rugino","year":"2014","unstructured":"Rugino TA. Effect on primary sleep disorders when children with ADHD are administered guanfacine extended release. J Atten Disord. 2014;22:14\u201324. \n                    https:\/\/doi.org\/10.1177\/1087054714554932\n                    \n                  .","journal-title":"J Atten Disord"},{"key":"39_CR20","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485\u201391.","journal-title":"Am J Ment Defic"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02211841","volume":"19","author":"C Lord","year":"1989","unstructured":"Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord. 1989;19:185\u2013212.","journal-title":"J Autism Dev Disord"},{"key":"39_CR22","volume-title":"The social communication questionnaire","author":"MBA Rutter","year":"2003","unstructured":"Rutter MBA, Lord C. The social communication questionnaire. Los Angeles, CA: Western Psychological Services; 2003."},{"key":"39_CR23","volume-title":"Psychiatric measures","author":"W Guy","year":"2000","unstructured":"Guy W. Clinical Global Impressions (CGI) Scale. In:Rush J, editors. Psychiatric measures. Washington, D.C: APA; 2000."},{"key":"39_CR24","first-page":"157","volume-title":"Advances in behavioral assessment of children and families","author":"RA Barkley","year":"1987","unstructured":"Barkley RA, Edelbrock C. Assessing situational variation in children\u2019s problem behaviors: the Home and School Situations Questionnaires. In: Prinz R, editors. Advances in behavioral assessment of children and families. Greenwich, CT: JAI Press Inc.; 1987. pp. 157\u201376."},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/1362361315593941","volume":"20","author":"M Chowdhury","year":"2016","unstructured":"Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, et al. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: the home situations questionnaire-autism spectrum disorder. Autism. 2016;20:528\u201337.","journal-title":"Autism"},{"key":"39_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/CHI.0b013e3181bfd669","volume":"48","author":"MG Aman","year":"2009","unstructured":"Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2009;48:1143\u201354.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR27","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/jama.2015.3150","volume":"313","author":"K Bearss","year":"2015","unstructured":"Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. JAMA. 2015;313:1524\u201333.","journal-title":"JAMA"},{"key":"39_CR28","volume-title":"Child symptom inventory-4","author":"KDSJ Gadow","year":"1994","unstructured":"Gadow KDSJ. Child symptom inventory-4. Stony Brook, NY: Checkmate Plus; 1994."},{"key":"39_CR29","volume-title":"Adolescent Symptom Inventory-4 screening manual","author":"KDSJ Gadow","year":"1997","unstructured":"Gadow KDSJ. Adolescent Symptom Inventory-4 screening manual. Stony Brook, NY: Checkmate Plus; 1997."},{"key":"39_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1207\/S15374424JCCP3104_10","volume":"31","author":"J Sprafkin","year":"2002","unstructured":"Sprafkin J, Gadow KD, Salisbury H, Schneider J, Loney J. Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys. J Clin Child Adolesc Psychol. 2002;31:513\u201324.","journal-title":"J Clin Child Adolesc Psychol"},{"key":"39_CR31","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s10803-013-1775-1","volume":"43","author":"V Hallett","year":"2013","unstructured":"Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord. 2013;43:2341\u201352.","journal-title":"J Autism Dev Disord"},{"key":"39_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","volume":"36","author":"L Scahill","year":"1997","unstructured":"Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. Children\u2019s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844\u201352.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR33","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","volume":"162","author":"CJ McDougle","year":"2005","unstructured":"McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162:1142\u20138.","journal-title":"Am J Psychiatry"},{"key":"39_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/01.chi.0000220854.79144.e7","volume":"45","author":"L Scahill","year":"2006","unstructured":"Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, et al. Children\u2019s Yale-Brown obsessive compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2006;45:1114\u201323.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR35","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","volume":"23","author":"JA Owens","year":"2000","unstructured":"Owens JA, Spirito A, McGuinn M. The children\u2019s sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000;23:1043\u201351.","journal-title":"Sleep"},{"key":"39_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2869.2010.00882.x","volume":"20","author":"F Giannotti","year":"2011","unstructured":"Giannotti F, Cortesi F, Cerquiglini A, Vagnoni C, Valente D. Sleep in children with autism with and without autistic regression. J Sleep Res. 2011;20:338\u201347.","journal-title":"J Sleep Res"},{"key":"39_CR37","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/sleep\/29.12.1563","volume":"29","author":"BA Malow","year":"2006","unstructured":"Malow BA, Marzec ML, McGrew SG, Wang L, Henderson LM, Stone WL. Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. Sleep. 2006;29:1563\u201371.","journal-title":"Sleep"},{"key":"39_CR38","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/0883073808331348","volume":"24","author":"HE Reed","year":"2009","unstructured":"Reed HE, McGrew SG, Artibee K, Surdkya K, Goldman SE, Frank K, et al. Parent-based sleep education workshops in autism. J Child Neurol. 2009;24:936\u201345.","journal-title":"J Child Neurol"},{"key":"39_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.sleep.2015.12.005","volume":"20","author":"CR Johnson","year":"2016","unstructured":"Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, et al. Psychometric properties of the children\u2019s sleep habits questionnaire in children with autism spectrum disorder. Sleep Med. 2016;20:5\u201311.","journal-title":"Sleep Med"},{"key":"39_CR40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2006.09.028","volume":"61","author":"DJ Posey","year":"2007","unstructured":"Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007;61:538\u201344.","journal-title":"Biol Psychiatry"},{"key":"39_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaac.2016.02.016","volume":"55","author":"L Scahill","year":"2016","unstructured":"Scahill L, Jeon S, Boorin SJ, McDougle CJ, Aman MG, Dziura J, et al. Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2016;55:415\u201323.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"39_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/cap.2014.0122","volume":"25","author":"AG Fiks","year":"2015","unstructured":"Fiks AG, Mayne SL, Song L, Steffes J, Liu W, McCarn B, et al. Changing patterns of alpha agonist medication use in children and adolescents 2009-2011. J Child Adolesc Psychopharmacol. 2015;25:362\u20137.","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0039-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0039-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0039-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:02:31Z","timestamp":1684602151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0039-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0039-3","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"29 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}